← Leaderboards
Kirsten B Moysich
Roswell Park Cancer Institute Corp
$9,727,320
Attributed
$12,668,183
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,348,398 · 15
By mechanism
P50$13,721,634 · 9
R01$6,300,475 · 2
R25$1,273,782 · 1
T32$693,458 · 1
R03$359,049 · 2
Top collaborators
- Jo L Freudenheim10 shared
- Kunle O Odunsi8 shared
- Brahm H. Segal6 shared
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Protul Shrikant$4,542,208
- Brahm H. Segal$5,088,454
- Adam R Karpf$2,229,203
- Scott I. Abrams$11,133,748
- Kevin Hasegawa Eng$501,839
Others in their field
Top investigators on “Malignant Neoplasm Of Ovary”
- David Heimbrook · Leidos Biomedical Research, Inc.$212,807,834
- Philip J Disaia · University Of California Irvine$127,836,851
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$32,228,202
- Larry Arthur$28,462,007
- Weiping Zou · University Of Michigan At Ann Arbor$24,295,958
- Robert C Bast · University Of Texas Md Anderson Can Ctr$22,987,143
Research focus
Malignant Neoplasm Of OvaryResourcesInterestResearch PersonnelFundingProgramsInstitutionAwardFutureMalignant NeoplasmsEnvironmentCareerUniversity Of Pittsburgh Cancer InstituteWomanTumorAdvocateInnovationFoundationsCollaborationsPilot ProjectsCancer Research ProjectResearch Project GrantsTranslational ResearchGrant
Grant awards (54)
Roswell Park Ovarian Cancer SPORE$1,787,915
P50 · FY2025 · CA · contact PI
Enhancing Personalized Care in Ovarian Cancer Through Prospective Exercise Interventions and AI-Driven Data Integration$198,657
P50 · FY2025 · CA · contact PI
Career Enhancement Program$198,657
P50 · FY2025 · CA · contact PI
Developmental Research Program$198,657
P50 · FY2025 · CA · contact PI
Administrative Core$198,657
P50 · FY2025 · CA · contact PI
Roswell Park Ovarian Cancer SPORE$1,745,539
P50 · FY2024 · CA · contact PI
Enhancing Personalized Care in Ovarian Cancer Through Prospective Exercise Interventions and AI-Driven Data Integration$378,669
P50 · FY2024 · CA · contact PI
Administrative Core$318,701
P50 · FY2024 · CA · contact PI
Career Enhancement Program$195,516
P50 · FY2024 · CA · contact PI
Developmental Research Program$184,783
P50 · FY2024 · CA · contact PI
Roswell Park Ovarian Cancer SPORE$1,147,484
P50 · FY2023 · CA · contact PI
Administrative Core$306,889
P50 · FY2023 · CA · contact PI
Career Enhancement Program$192,976
P50 · FY2023 · CA · contact PI
Developmental Research Program$182,581
P50 · FY2023 · CA · contact PI
Roswell Park Ovarian Cancer SPORE$1,532,970
P50 · FY2022 · CA · contact PI
Career Enhancement Program$194,420
P50 · FY2022 · CA · contact PI
Developmental Research Program$183,237
P50 · FY2022 · CA · contact PI
Roswell Park Ovarian Cancer SPORE$1,716,101
P50 · FY2021 · CA · contact PI
Career Enhancement Program$188,717
P50 · FY2021 · CA · contact PI
Interdisciplinary Training in Cancer Epidemiology at UB$184,469
T32 · FY2021 · CA
Developmental Research Program$178,656
P50 · FY2021 · CA · contact PI
Interdisciplinary Training in Cancer Epidemiology at UB$152,601
T32 · FY2020 · CA
Novel immunological biomarkers ovarian cancer prognosis$613,871
R01 · FY2019 · CA
A CRISPR-based platform for testing neutrophil responses in the ovarian cancer microenvironment$207,918
R01 · FY2019 · CA
Interdisciplinary Training in Cancer Epidemiology at UB$119,230
T32 · FY2019 · CA
RPCI-UPCI Ovarian Cancer SPORE$1,750,206
P50 · FY2018 · CA · contact PI
Novel immunological biomarkers ovarian cancer prognosis$632,858
R01 · FY2018 · CA
Interdisciplinary Training in Cancer Epidemiology at UB$97,463
T32 · FY2018 · CA
Novel immunological biomarkers ovarian cancer prognosis$646,389
R01 · FY2017 · CA
Interdisciplinary Training in Cancer Epidemiology at UB$139,695
T32 · FY2017 · CA
Developmental Research Program$67,249
P50 · FY2017 · CA · contact PI
Novel immunological biomarkers ovarian cancer prognosis$646,389
R01 · FY2016 · CA
Interdisciplinary Training in Cancer Epidemiology at UB$264,730
R25 · FY2016 · CA
Developmental Research Program$1,320
P50 · FY2016 · CA · contact PI
Novel immunological biomarkers ovarian cancer prognosis$589,735
R01 · FY2015 · CA
Interdisciplinary Training in Cancer Epidemiology at UB$266,333
R25 · FY2015 · CA
Myeloid Derived Suppressor Cells in Ovarian Carcinogenesis$94,889
P50 · FY2015 · CA · contact PI
Developmental Research Program$48,893
P50 · FY2015 · CA · contact PI
Interdisciplinary Training in Cancer Epidemiology at UB$262,900
R25 · FY2014 · CA
Myeloid Derived Suppressor Cells in Ovarian Carcinogenesis$85,698
P50 · FY2014 · CA · contact PI
Developmental Research Program$59,682
P50 · FY2014 · CA · contact PI
Regulatory T Cell Function in Ovarian Cancer$542,599
R01 · FY2013 · CA · contact PI
Interdisciplinary Training in Cancer Epidemiology at UB$254,135
R25 · FY2013 · CA
Myeloid Derived Suppressor Cells in Ovarian Carcinogenesis$226,305
P50 · FY2013 · CA · contact PI
Developmental Research Program$157,610
P50 · FY2013 · CA · contact PI
Regulatory T Cell Function in Ovarian Cancer$587,055
R01 · FY2012 · CA · contact PI
Interdisciplinary Training in Cancer Epidemiology at UB$225,684
R25 · FY2012 · CA
Regulatory T Cell Function in Ovarian Cancer$641,563
R01 · FY2011 · CA · contact PI
Regulatory T Cell Function in Ovarian Cancer$629,546
R01 · FY2010 · CA · contact PI
Regulatory T Cell Function in Ovarian Cancer$562,552
R01 · FY2009 · CA · contact PI
Pharmacogenetics in Ovarian Cancer$96,857
R03 · FY2007 · CA · contact PI
Pharmacogenetics in Ovarian Cancer$99,750
R03 · FY2006 · CA · contact PI
Use of Stored Bone Marrow Samples for Pharmacogenetic S*$84,355
R03 · FY2005 · CA
Pharmacogenetic Studies of Acute Myeloid Leukemia$78,087
R03 · FY2004 · CA